While the observed level of DNA damage in our ATRX-deficient cell line and tumor models was insufficient to induce apoptosis in isolation, due in part to coincident TP53 inactivation, we hypothesized that its targeted enhancement would overwhelm compensatory mechanisms maintaining cell viability (Fig. 9). The gene discussed is ATRX; the disease is neoplasm.